Robeco Institutional Asset Management B.V. Purchases 2,180 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Robeco Institutional Asset Management B.V. increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA – Get Rating) by 3.9% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 58,276 shares of the company’s stock after acquiring an additional 2,180 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in HCA Healthcare were worth $10,713,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Bridgefront Capital LLC bought a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $219,000. Eagle Bay Advisors LLC grew its position in shares of HCA Healthcare by 56.7% in the 3rd quarter. Eagle Bay Advisors LLC now owns 210 shares of the company’s stock valued at $39,000 after buying an additional 76 shares during the last quarter. CVA Family Office LLC grew its position in shares of HCA Healthcare by 19.1% in the 3rd quarter. CVA Family Office LLC now owns 560 shares of the company’s stock valued at $103,000 after buying an additional 90 shares during the last quarter. B. Riley Wealth Advisors Inc. grew its position in shares of HCA Healthcare by 329.6% in the 3rd quarter. B. Riley Wealth Advisors Inc. now owns 7,393 shares of the company’s stock valued at $1,359,000 after buying an additional 5,672 shares during the last quarter. Finally, Teachers Retirement System of The State of Kentucky bought a new stake in shares of HCA Healthcare in the 3rd quarter valued at about $22,712,000. Institutional investors own 64.60% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other news, CFO Bill B. Rutherford sold 30,000 shares of the firm’s stock in a transaction on Friday, February 3rd. The stock was sold at an average price of $258.19, for a total value of $7,745,700.00. Following the completion of the transaction, the chief financial officer now directly owns 81,632 shares of the company’s stock, valued at $21,076,566.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CFO Bill B. Rutherford sold 30,000 shares of the firm’s stock in a transaction on Friday, February 3rd. The stock was sold at an average price of $258.19, for a total value of $7,745,700.00. Following the completion of the transaction, the chief financial officer now directly owns 81,632 shares of the company’s stock, valued at $21,076,566.08. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Jon M. Foster sold 16,424 shares of the stock in a transaction on Wednesday, February 1st. The stock was sold at an average price of $251.98, for a total value of $4,138,519.52. Following the completion of the sale, the chief operating officer now owns 10,938 shares in the company, valued at approximately $2,756,157.24. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 79,899 shares of company stock valued at $20,460,494. Company insiders own 1.50% of the company’s stock.

HCA Healthcare Stock Down 1.5 %

HCA stock opened at $250.66 on Friday. The firm has a market cap of $69.50 billion, a PE ratio of 13.03, a P/E/G ratio of 1.77 and a beta of 1.64. The business has a 50 day moving average of $254.15 and a 200-day moving average of $231.94. HCA Healthcare, Inc. has a 12-month low of $164.47 and a 12-month high of $279.02.

HCA Healthcare (NYSE:HCA – Get Rating) last announced its quarterly earnings data on Friday, January 27th. The company reported $4.64 earnings per share for the quarter, missing the consensus estimate of $4.79 by ($0.15). HCA Healthcare had a net margin of 9.37% and a negative return on equity of 1,260.96%. The firm had revenue of $15.50 billion for the quarter, compared to the consensus estimate of $15.51 billion. On average, research analysts expect that HCA Healthcare, Inc. will post 17.16 earnings per share for the current year.

HCA Healthcare announced that its board has authorized a share buyback plan on Friday, January 27th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the company to reacquire up to 4.2% of its stock through open market purchases. Stock buyback plans are typically a sign that the company’s leadership believes its stock is undervalued.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 31st. Shareholders of record on Friday, March 17th will be issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.96%. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.56. The ex-dividend date is Thursday, March 16th. HCA Healthcare’s dividend payout ratio is 11.65%.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the company. Cowen boosted their price objective on HCA Healthcare from $238.00 to $292.00 and gave the company an “outperform” rating in a research note on Monday, January 30th. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, March 13th. Mizuho boosted their price objective on HCA Healthcare from $265.00 to $279.00 and gave the company a “buy” rating in a research note on Monday, January 30th. Stephens reaffirmed an “overweight” rating and set a $283.00 price target on shares of HCA Healthcare in a research note on Monday, March 13th. Finally, Raymond James upped their price target on HCA Healthcare from $230.00 to $300.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 31st. One research analyst has rated the stock with a sell rating, one has issued a hold rating and eighteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $269.41.

HCA Healthcare Company Profile

(Get Rating)

HCA Healthcare, Inc is a health care services company engaged in operating hospitals, freestanding surgery centers and emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, comprehensive rehabilitation and physical therapy centers, physician practices, home health, hospice, outpatient physical therapy home and community-based services providers, and various other facilities.